How big is the endocrine testing market?

The global endocrine testing market size was estimated at USD 14.35 billion in 2025 and is expected to reach USD 15.46 billion in 2026.

What is the endocrine testing market growth?

The global endocrine testing market is expected to grow at a compound annual growth rate of 8.48% from 2026 to 2033 to reach USD 27.32 billion by 2033.

Which segment accounted for the largest endocrine testing market share?

North America dominated the endocrine testing market with a share of 39.7% in 2025. This is attributable to the presence of well-established healthcare infrastructure, rising prevalence of diabetic & obese population and favorable healthcare reimbursement scenarios in the North American region.

Who are the key players in endocrine testing market?

Some key players operating in the global endocrine testing market include Abbott Laboratories; AB Sciex; Agilent Technologies, Inc.; bioMerieux SA, Bio-Rad Laboratories, Inc.; DiaSorin S.p.A; F. Hoffmann-La Roche Ltd.; Ortho Clinical Diagnostics; Laboratory Corporation of America Holdings (LabCorp); and Quest Diagnostics Incorporated.

What are the factors driving the endocrine testing market?

Key factors that are driving the global endocrine testing market growth include growing incidences of life style diseases, endocrine disorders & awareness of reproductive functions such as obesity, hyperthyroidism, diabetes, infertility and adrenal insufficiency.